Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine Mechanism of Action on GDF15
NCT04355585Phase 1Unknown
- Sponsor
- Brigham and Women's Hospital
- Start
- May 2020
- Primary completion
- Apr 2023
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in gout comparing Colchicine with Placebo (2 arms). Primary endpoint: Plasma Growth Differentiation Factor 15 levels at 48 hours. Status: unknown.
02
Drugs
colchicine
03
Conditions
gout
Beyond the preview
Go deeper on NCT04355585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04355585.